Laronde is pioneering a platform that offers a completely novel way of modulating human biology. Endless RNA™ (eRNA), is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.
| Website | http://laronde.bio |
| Employees | 43 (16 on RocketReach) |
| Founded | 2017 |
| Address | 55 Cambridge Pkwy Suite 800E, Cambridge, Massachusetts 02142, US |
| Industry | Biotechnology |
| Keywords | Innovative Therapies, Rna Therapeutics, Protein Expression, Genetic Engineering, Precision Medicine, Biotechnology, Drug Delivery, Personalized Medicine, Rna Modification, Human Biology, Biomedical Research, Molecular Biology, Gene Therapy, Pharmaceutical Research, Bioengineering, Therapeutic Proteins, Rna Technology, Novel Therapeutics, Biological Engineering |
| Competitors | Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Moderna Therapeutics, Intellia Therapeutics, Inc., CRISPR Therapeutics, Editas Medicine, Sangamo Therapeutics, Inc. +35 more (view full list) |
Looking for a particular Laronde employee's phone or email?
16 people are employed at Laronde.
Laronde is based in Cambridge, Massachusetts.